If numbers tell the story… Pfizer reported that profits tripled thanks to higher sales of the Lyrica pain pill Lyrica and lower costs from 11,000 jobs that were cut last year. Net income rose to $2.28 billion, or 34 cents a share, from $761 million, or 11 cents, a year earlier, when Pfizer took a $2.8 billion charge for the Exubera inhaled insulin device. Revenue was roughly flat at $12 b...
Meds Finder
Get smart about meds...
Your browser's security settings are preventing some features from appearing. See instructions for fixing the problem.
Report item as: (required) X Obscenity/vulgarity Hate speech Personal attack Advertising/Spam Copyright/Plagiarism Other Comment: (optional) Missing input fields. You must fill out the comment body in order to submit a comment. Comment too long. The comment you have en...
$100M for poor nations fighting climate change: PM...
$100 million for other countries to fight climate change? Where is that money going to come from, some new tax??
This action makes it clear why Prime Minister Harper is well respected on the world stage.
If he could campaign likes he runs Canada he would have a majority.
That's good lets ignore our problems here and pump 100 million of our money out somewhere else. I am not d...
Cards continue to save locals cash on meds...
Your browser's security settings are preventing some features from appearing. See instructions for fixing the problem.
Report item as: (required) X Obscenity/vulgarity Hate speech Personal attack Advertising/Spam Copyright/Plagiarism Other Comment: (optional) Missing input fields. You must fill out the comment body in order to submit a comment. Comment too long. The comment you have ent...
What faith calls us to do — together...
Garrison Keillor has a poetic, almost sappy, way of writing his columns. He know doubt leaves himself open to criticism. Using the flowery … read more generalization method, he invites negative comments. And, of course, because he is a "lefty", those on the other side of the ideological spectrum will attack him for his past sins. However, I think the country is seeing a real leader in Ob...
Pfizer: $900M To Settle Bextra & Celebrex Suits...
The drugmaker reached agreements in principle to resolve "substantially all" of the personal injury cases, consumer fraud cases and state attorneys general claims involving its two Cox-2 inhibitor painkillers. Bextra, you may recall, was withdrawn three years ago, while Celebrex remains available.
Here's the breakdown: $745 million applicable to personal injury claims, $60 million for st...
Stopping The Bleeding: A Race To Treat Blood Clots...
Several big drug makers are in a neck-and-neck race to introduce new drugs for treating blood clots, and the prize is a piece of a market estimated to be worth about $20 billion by 2016, The Wall Street Journal writes.
Current treatments are effective and sell well but have problems - one is difficult to dose and has risks when taken with other meds and some foods, while another is an inj...
Review: Filth and Wisdom...
First time? A confirmation email will be sent to you after submitting.
Your comments: Remember me E-Mail me when someone replies to this commentPlease keep your comments relevant to this blog entry. Email addresses are never displayed, but they are required to confirm your comments.
When you enter your name and email address, you'll be sent a link to confirm your comment, and a...
The ‘King of Viagra’ Is Jailed For Fraud...
A doctor has been jailed for three years for his role in a multi-million pound plot to sell fake versions of the little blue impotence pill, the BBC reports.
George Patino, who sold thousands of counterfeit impotence tablets to customers over the Internet, pleaded guilty at Kingston Crown Court and was described a "disgrace to his profession" by the judge. The 48-year-old Mexican national...
FDA Pushed Industry’s ‘Voluntary’ Ban on Cold Meds for Young Kids...
WSJ's Health Blog offers news and analysis on health and the business of health. The lead writer is Jacob Goldstein. He came to The Wall Street Journal from the Miami Herald, where he was a medical writer. Scott Hensley, who covered the drug industry as a reporter for the Journal for seven years, is the editor and also a contributor. The blog also includes contributions from other staffers at ...
User login
Browse archives
Who's online
There are currently 0 users and 13 guests online.
Syndicate
